Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

Emanuel Zitt, Denis Fouque, Stefan H Jacobson, Fabio Malberti, Miroslav Ryba, Pablo Ureña, Marianne Rix, Bastian Dehmel, Nick Manamley, Marc Vervloet

    23 Citationer (Scopus)

    Abstract

    The calcimimetic cinacalcet lowers parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) in dialysis patients with secondary hyperparathyroidism (SHPT). We explored serum P changes in dialysis patients treated with cinacalcet, while controlling for vitamin D sterol and phosphate binder (PB) changes, based on data from the pan-European observational study ECHO.
    OriginalsprogEngelsk
    TidsskriftClinical kidney journal
    Vol/bind6
    Udgave nummer3
    Sider (fra-til)287-294
    Antal sider8
    ISSN2048-8505
    DOI
    StatusUdgivet - jun. 2013

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction'. Sammen danner de et unikt fingeraftryk.

    Citationsformater